EV/EBITDA
N/A
Sat, 08 Mar 2025 00:17:50 GMT
Summary
- AZN EV/EBITDA is not available.
Performance
AZN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AZN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | - | - | -0.8% |
| 1 m1 month | - | - | +7.4% |
| 3 m3 months | - | - | +13.5% |
| 6 m6 months | - | - | -6.5% |
| ytdytd | - | - | +17.9% |
| 1 y1 year | - | - | +17.4% |
| 5 y5 years | - | - | +62.7% |
AZN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | 14.48 | |||
| 3 m | 3-month | 16.08 | 13.31 | ||
| 6 m | 6-month | 20.08 | 13.31 | ||
| 1 y | 1-year | 21.25 | 13.31 | ||
| 3 y | 3-year | 50.79 | 13.31 | ||
| 5 y | 5-year | 50.79 | 13.31 | ||
| alltime | all time | 152.76 | -50.57 |
AstraZeneca EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 13.31(-23.1%) |
| 2023 | 17.30(-32.6%) |
| 2022 | 25.67(-33.0%) |
| 2021 | 38.32(+115.4%) |
| 2020 | 17.79(-16.9%) |
| 2019 | 21.41(+37.7%) |
| 2018 | 15.55(+0.7%) |
| 2017 | 15.44(+38.7%) |
| 2016 | 11.13(-18.2%) |
| 2015 | 13.61(-20.1%) |
| 2014 | 17.03(+87.3%) |
| 2013 | 9.09(+57.0%) |
| 2012 | 5.79(+43.3%) |
| 2011 | 4.04(-6.3%) |
| 2010 | 4.31(-13.3%) |
| 2009 | 4.97(+11.4%) |
| Date | Value |
|---|---|
| 2008 | 4.46(-38.1%) |
| 2007 | 7.20(-9.7%) |
| 2006 | 7.97(-16.0%) |
| 2005 | 9.49(-7.6%) |
| 2004 | 10.27(-33.3%) |
| 2003 | 15.40(+26.5%) |
| 2002 | 12.17(-25.5%) |
| 2001 | 16.33(-11.6%) |
| 2000 | 18.48(+91.5%) |
| 1999 | 9.65(-81.4%) |
| 1998 | 51.75(+235.4%) |
| 1997 | 15.43(+127.2%) |
| 1996 | 6.79(-114.7%) |
| 1995 | -46.08(-584.5%) |
| 1994 | 9.51(-11.4%) |
| 1993 | 10.73 |
FAQ
- What is the all time high EV/EBITDA for AstraZeneca?
What is the all time high EV/EBITDA for AstraZeneca?
AstraZeneca all-time high EV/EBITDA is 152.76